Malignant disease often produces a range of complications, some potentially life-threatening, either from the disease itself or from the effects of treatment. The early detection and accurate diagnosis and treatment of these complications can both improve quality of life and increase the survival time of a patient. It is thus important to be able to recognise oncological emergencies that may arise in cancer patients who may present in the general practice setting.
Brain Neoplasm - Diagnosis

Brain metastasis from primary uterine cervical carcinoma have been described but are extremely rare and usually occur in the presence of widely disseminated diseases. The authors report a case of solitary cerebellar metastasis from uterine cervical carcinoma, which was confirmed by histopathological examination. The patient has shown no evidence of metastatic lesions elsewhere, thus far, but had undergone a radical hysterectomy under the diagnosis of uterine cervical carcinoma 52 months prior to the surgical excision of the cerebellar metastasis.
Brain ; Diagnosis ; Humans ; Hysterectomy ; Neoplasm Metastasis*

The authors analyzed and compared three prognostic factors of the intraparenchymal metastatic brain tumors, regardless of therapeutic modalities, to evaluate the value of time-interval between diagnosis of primary cancer and brain metastasis as a prognostic factor. Our of the 109 patients of metastatic brain tumor admitted to Kosin Medical College from 1984 to 1991, 93 patients were included in this retrospective study. The survival time of these patients was statistically evaluated according to each prognostic factor. The results were as follows. Patients with mild or no neurological deficits and patients with moderate neurological deficits showed longer survival than the patients with severe neurological deficits(P<0.001). The presence of systemic metastasis at the time of diagnosis also significantly shortened overall survival(P<0.0095). Primary-to-metastatic interval did not significantly affect overall survival(P<0.6164), but the patients with brain metastasis detected within 1 year after diagnosis of the primary cancer had a longer median survival than those detected after 1 year(P<0.001). We conclude that the primary-to-metastatic interval is not valuable as a prognostic factor for intraparenchymal metastatic brain tumor, and further prospective study tailored to each specific condition will be needed for more accurate evaluation of prognostic factors.
Brain Neoplasms ; Brain* ; Diagnosis ; Humans ; Neoplasm Metastasis* ; Prognosis* ; Retrospective Studies

OBJECTIVE: Neurosurgical technique has recently entered a fantastic era of image guided surgery or neuronavigaton and application of this technology is beginning to have a significant impact on a variety of intracranial procedures. This study purports to investigate the effectiveness of this new technique in its application to the brain tumor surgery. METHODS: We used the BrainLab VectorVision neuronavigation system, which is an intraoperative, imageguided, frameless, and localization system. We operated 220 cases of different brain pathological conditions with its guidance. RESULTS: The mean of target localizing accuracy, mass size, and mass volume were 1.14mm, 3.04x3.78cm, 32.04cc respectively. These cases included 194 microsurgical craniotomies, 21 frameless stereotactic biopsies, 4 endoscopic procedure and 1 catheter placement. The common pathological diagnoses were meningioma in 61 cases, glioma in 59 and metastasis in 45. CONCLUSION: The neuronavigation system has shown to be very effective and user-friendly for routine microsurgical interventions. The application of this technique not only revealed benefits in operative planning, appreciation of anatomy, lesion location, and safety of surgery, but also greatly enhanced surgical confidence. The image guided surgical technology has a great potential to play an important role in contemporary neurosurgery and its various adoptions in practice will be realized in the near future.
Biopsy ; Brain Neoplasms* ; Brain* ; Catheters ; Craniotomy ; Diagnosis ; Glioma ; Meningioma ; Neoplasm Metastasis ; Neuronavigation* ; Neurosurgery ; Surgery, Computer-Assisted

An atypical teratoid/rhabdoid tumor (AT/RT) is a rare malignancy occurring in the first few years of life. This tumor shows rapid growth, a poor response to treatment, and poor prognosis. Cutaneous metastases presents as hamartomatous lesions mimicking skin tags. Immunohistochemical examination shows varied patterns of expression based on the sites of the body affected. Integrase interactor-1 (INI-1) gene sequencing and loss of expression of INI-1 observed with immunostaining can confirm AT/RT. In our patient, the skin lesion was identified at birth. Histopathological examination of the skin lesion could not establish an accurate diagnosis. Two months later, the patient presented with a brain tumor. Immunohistochemical examination of the brain lesion revealed complete loss of INI-1 expression in tumor cells, and the lesion was diagnosed as AT/RT. After that, we can detect the loss of INI-1 expression in the skin on the back. We report a rare case of AT/RT affecting the brain with cutaneous metastasis diagnosed with immunohistochemical staining.
Brain ; Brain Neoplasms ; Diagnosis ; Humans ; Integrases ; Neoplasm Metastasis ; Parturition ; Prognosis ; Skin

OBJECTIVETo evaluate the role of perfusion weighted imaging (PWI) in the differentiation between recurrent glioma and radiation-induced brain injuries.

METHODSTwenty-three patients with previously resected and irradiated glioma, presenting newly developed abnormal enhancement, were included in the study. The final diagnosis was determined either histologically or clinicoradiologically. PWI was obtained with a gradient echo echo-planar-imaging (GRE-EPI)technique. The normalized relative cerebral blood volume (rCBV) ratio [rCBV (abnormal enhancement)/rCBV (contralateral tissue)], relative cerebral blood flow (rCBF) ratio [rCBF (abnormal enhancement)/rCBF(contralateral tissue)], mean transit time(MTT) ratio [MTT (abnormal enhancement)/MTT(contralateral tissue)],time to peak(TTP)ratio[TTP(abnormal enhancement)/TTP(contralateral tissue)],and bolus arrive time(BAT)ratio[BAT(abnormal enhancement)/BAT(contralateral tissue)] were calculated. The regions of interest (ROIs) consisting of 20-40mm(2) were placed in the abnormal enhanced areas on postcontrast T1-weighted images.Ten ROIs measurements were performed in each lesion.T test was used to determine whether there was a difference in the rCBV/rCBF/rMTT/rTTP/rBAT ratios between recurrent glioma and irradiated injuries.Significance was set to a P value <0.05.

RESULTSThirteen of the 23 patients were proved recurrent glioma and 10 were proved radiation-induced brain injuries. The rCBV ratio (3.60±3.86 vs. 0.82 ± 0.74, P = 0.000)and rCBF ratio (2.88 ± 2.27 vs. 0.84 ± 0.80, P = 0.000) in glioma recurrence were markedly higher than those in radiation injuries. The areas under rCBV and rCBF ROC curve were both 0.8763. rMTT (P=0.204), rTTP (P=0.260), and rBAT (P=0.071) ratios showed no statistical difference between the two groups.

CONCLUSIONPWI is an effective technique in distinguishing glioma recurrence from radiation injuries,and the ratios of rCBV and rCBF ratio differential diagnosis of critical value to 1.3088 and 1.1235, respectively, can be used as a reliable clinical indicator.

Adult ; Aged ; Brain Injuries ; diagnosis ; Brain Neoplasms ; diagnosis ; Diagnosis, Differential ; Female ; Glioma ; diagnosis ; Humans ; Magnetic Resonance Angiography ; methods ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; diagnosis ; Radiation Injuries ; diagnosis

Multiple intracerebral space-occupying lesions (SOL) demonstrated by computed tomography (CT), magnetic resonance imaging (MRI), and radionuclide brain scanning or cerebral arteriography often present a diagnostic enigma. The differential diagnosis between brain abscess and brain tumor is occasionally difficult to determine on the basis of imaging studies and clinical judgement, especially in the case of brain SOL with mainly cystic or necrotic component. Elderly patients with a history suggestive of hidden malignancy and the above radiological features are usually presumptively diagnosed as having multiple cerebral metastases. We experienced a case of multiple brain abscess which was confirmed by diagnostic surgery, in a 67- year old male who showed clinical and radiological findings of mimicking cystic brain metastases with undetermined primary focus. Even with long-term therapy with antibiotics and supportive care, the patient suffered from massive ventriculitis and subsequently died.
Aged ; Angiography ; Anti-Bacterial Agents ; Brain Abscess* ; Brain Neoplasms ; Brain* ; Diagnosis, Differential ; Humans ; Magnetic Resonance Imaging ; Male ; Neoplasm Metastasis*

PURPOSE: To evaluate the usefulness of dynamic MR imaging in the differential diagnosis of intracranial tumorand abscess. MATERIALS AND METHODS: Dynamic MR images of 36 patients with surgically or clinically provenintracranial enhancing lesions were retrospectively reviewed. These lesions comprised 15 metastases, 14 gliomas,and seven abscesses. Images were sequentially obtained every 30 seconds for 3-5 minutes using the spin-echotechnique(TR/TE : 200 msec/15 msec) after bolus injection of gadolinium dimeglumine(2-3cc/sec). The dynamics ofcontrast enhancement of the lesions was analyzed visually and by calculating the sequential contrast-enhancementratio(CER). RESULTS: CER during the 30-second early dynamic phase was 93.16 in metastases, 67.78 in gliomas, and48.3 in abscesses(ANOVA, p<0.005). The contrast enhancement pattern of metastases showed rapidly increased signalintensity(SI) up to 30 seconds, followed by a relatively rapid decrease; less time was then required to reach theCER peak. In gliomas, SI increased gradually up to 180 seconds and then took a longer time to reach the CER peak.The SI of abscesses was similar to that of gliomas, with a more gradual increase for 30-60 seconds and a longertime for the CER peak to be reached. CONCLUSION: The contrast enhancement pattern and CER parameters seen ondynamic MRI can help differentiate intracranial tumor and abscess.
Abscess ; Brain Abscess* ; Brain Neoplasms* ; Brain* ; Diagnosis, Differential ; Gadolinium ; Glioma ; Humans ; Magnetic Resonance Imaging* ; Neoplasm Metastasis ; Retrospective Studies

PURPOSE: The purpose of this study was to evaluate the usefulness of diffusion-weighted imaging (DWI) for the differential diagnosis of various intracranial cystic lesions. MATERIALS AND METHODS: This study included 19 patients (13 males, 6 females) with a mean age of 42.5 years. The final histopathological diagnoses for 14 patients were pyogenic brain abscess (n=3), glioblastoma (n=3), ependymoma (n=1), anaplastic astrocytoma (n=1), pilocytic astrocytoma (n=1), hemangioblastoma (n=2), arachnoid cyst (n=1), epidermoid (n=1) and schwannoma (n=1). The other cases of metastasis (n=4) and arachnoid cyst (n=2) were diagnosed on the basis of clinical, laboratory and imaging data. DWI imaging studies were performed with a 1.5 T MR system. A single shot spin echo EPI pulse sequence was applied. B values were set at 0 and 1000 sec/mm2. The apparent diffusion coefficient (ADC) were calculated from the ADC map of 10 different cystic brain lesions. Conventional MR imaging included T2WI, T1WI, FLAIR and contrast enhanced T1WI. We analyzed the location, nature, signal intensity on DWI, and the enhancement pattern of the lesions. RESULTS: All of the 3 cases of brain abscess, 1 of 4 cases of metastasis and 1 case of epidermoid showed hyperintensity on DWI. The mean ADC value of brain abscess (2 cases) was less than 1.15 (0.13x10-3 mm2/s). The mean ADC values of the other cystic lesions (8 cases) were variable, ranging from 2.840.66 to 3.100.16 (10-3 mm2/sec). CONCLUSION: DWI and ADC values were useful in the differential diagnosis of various intracranial cystic lesions, but some metastatic tumors may mimic a brain abscess on DWI. Therefore, a clinical correlation is mandatory.
Arachnoid ; Astrocytoma ; Brain ; Brain Abscess ; Diagnosis ; Diagnosis, Differential* ; Diffusion* ; Ependymoma ; Glioblastoma ; Hemangioblastoma ; Humans ; Magnetic Resonance Imaging ; Male ; Neoplasm Metastasis ; Neurilemmoma

BACKGROUND: Up to 15% of all patients with brain metastases have no clearly detected primary site despite intensive evaluation, and this incidence has decreased with the use of improved imaging technology. Radiosurgery has been evaluated as one of the treatment modality for patients with limited brain metastases. In this study, we evaluated the effectiveness of radiosurgery for brain metastases from unknown primary tumors. METHODS: We retrospectively evaluated 540 patients who underwent gamma knife radiosurgery (GKRS) for brain metastases radiologically diagnosed between August 1992 and September 2007 in our institution. First, the brain metastases were grouped into metachronous, synchronous, and precocious presentations according to the timing of diagnosis of the brain metastases. Then, synchronous and precocious brain metastases were further grouped into 1) unknown primary; 2) delayed known primary; and 3) synchronous metastases according to the timing of diagnosis of the primary origin. We analyzed the survival time and time to new brain metastasis in each group. RESULTS: Of the 540 patients, 29 (5.4%) presented precocious or synchronous metastases (34 GKRS procedures for 174 lesions). The primary tumor was not found even after intensive and repeated systemic evaluation in 10 patients (unknown primary, 34.5%); found after 8 months in 3 patients (delayed known primary, 1.2%); and diagnosed at the same time as the brain metastases in 16 patients (synchronous metastasis, 55.2%). No statistically significant differences in survival time and time to new brain metastasis were found among the three groups. CONCLUSION: Identification of a primary tumor before GKRS did not affect the patient outcomes. If other possible differential diagnoses were completely excluded, early GKRS can be an effective treatment option for brain metastases from unknown primary tumor.
Brain* ; Diagnosis ; Diagnosis, Differential ; Humans ; Incidence ; Neoplasm Metastasis* ; Neoplasms, Unknown Primary ; Radiosurgery* ; Retrospective Studies